Cited by 156Parkinson's Disease Mechanisms and TreatmentsInflammasome and immune disordersNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats

Mao, Zhijuan, Liu, Chanchan, Ji, Suqiong, Yang, Qingmei, Ye, Hongxiang, Han, Haiyan, Xue, Zheng·2017·Neurochemical Research

DOI 10.1007/s11064-017-2185-0

Open this paper in CoChat — free account

Abstract

The etiology and pathogenesis of Parkinson's disease (PD) are complicated and have not been fully elucidated, but an important association has been identified between inflammation and PD. In this study, we investigated the role of the nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain-containing (NLRP) 3 inflammasome, consisting of NLRP3, caspase-1 and cytokines of the IL-1 family, in lipopolysaccharide (LPS)-induced and 6-hydroxydopamine (6-OHDA)-induced PD rats. Microinjection of different doses of caspase-1 inhibitor (Ac-YVAD-CMK, 300 or 1200 ng/rat) was performed for seven consecutive days. Then, rotational behavior, the number of dopamine (DA) neurons in the substantia nigra pars compacta (SNc), and the mRNA and protein expression levels of NLRP3 inflammasome components were measured 14 days after the microinjection setup was established. Results showed that high mRNA and protein expression levels of NLRP3 inflammasome components were observed in the injected side of the LPS- and 6-OHDA-induced PD rats; Ac-YVAD-CMK inhibited the mRNA and protein expression of NLRP3 inflammasome components in both LPS- and 6-OHDA-induced PD rats. Moreover, the number of rotations was significantly decreased, and the number of DA neurons in the SNc improved. Our data indicate that the NLRP3 inflammasome participates in the pathogenesis of PD and that inhibiting the downstream pathway of the NLRP3/caspase-1/IL-1β axis can alleviate the occurrence of PD symptoms, providing a new basis for the prevention and treatment of PD.

Integrity signals

Registry

Crossref · 10.1007/s11064-017-2185-0

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
Moon, J.-S., Hisata, S., Park, M. A., DeNicola, G. M., Ryter, S. W., Nakahira, K., & Choi, A. M. K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.046 · Cited by 379
Retracted
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Neurodegenerative Disorders: Parkinson's Disease and Huntington's Disease
Hague, S., Klaffke, S., & Bandmann, O. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860948961_0007 · Cited by 2,767
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658

Show all 52 references

Sorted by citations

The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology
Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821
Inflammasomes in neuroinflammatory and neurodegenerative diseases
Voet, S., Srinivasan, S., Lamkanfi, M., & van Loo, G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810248 · Cited by 761
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease
Wang, S., Yuan, Y., Chen, N., & Wang, H. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.019 · Cited by 452
MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration
Lee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431
Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Schmidt, M. F., Gan, Z. Y., Komander, D., & Dewson, G. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00706-7 · Cited by 379
Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis
Calabrese, V., Santoro, A., Monti, D., Crupi, R., Di Paola, R., Latteri, S., Cuzzocrea, S., Zappia, M., Giordano, J., Calabrese, E. J., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.379 · Cited by 356
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J. R., & Gaskill, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 328
The IL-1β phenomena in neuroinflammatory diseases
Mendiola, A. S., & Cardona, A. E. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1732-9 · Cited by 328
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Xu, W., Huang, Y., & Zhou, R. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01275-w · Cited by 355
Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson's Disease
Haque, M. E., Akther, M., Jakaria, M., Kim, I., Azam, S., & Choi, D. (2019) · Movement Disorders · doi:10.1002/mds.27874 · Cited by 251
The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease
Zhang, C., Zhao, M., Wang, B., Su, Z., Guo, B., Qin, L., Zhang, W., & Zheng, R. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102134 · Cited by 208
Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases
Wu, A., Zhou, X., Qiao, G., Yu, L., Tang, Y., Yan, L., Qiu, W., Pan, R., Yu, C., Law, B. Y. K., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101202 · Cited by 196
NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease
von Herrmann, K. M., Salas, L. A., Martinez, E. M., Young, A. L., Howard, J. M., Feldman, M. S., Christensen, B. C., Wilkins, O. M., Lee, S., Hickey, W. F., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0061-5 · Cited by 190
Manganese activates NLRP3 inflammasome signaling and propagates exosomal release of ASC in microglial cells.
Sarkar, S., Rokad, D., Malovic, E., Luo, J., Harischandra, D. S., Jin, H., Anantharam, V., Huang, X., Lewis, M., Kanthasamy, A., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aat9900 · Cited by 171
Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson’s Disease via Regulating miR-7/NLRP3 Pathway
Cao, B., Wang, T., Qu, Q., Kang, T., & Yang, Q. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.019 · Cited by 167
Self-citation
NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea
Wu, X., Gong, L., Xie, L., Gu, W., Wang, X., Liu, Z., & Li, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628168 · Cited by 172
LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease
Cai, L.-J., Tu, L., Huang, X.-M., Huang, J., Qiu, N., Xie, G., Liao, J.-X., Du, W., Zhang, Y., & Tian, J. (2020) · Molecular Brain · doi:10.1186/s13041-020-00656-8 · Cited by 156
Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases
Zhang, X., Xu, A., Lv, J., Zhang, Q., Ran, Y., Wei, C., & Wu, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111822 · Cited by 148
The immune system in Parkinson's disease: what we know so far
Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 151
Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice
Dong, Y., Li, S., Lu, Y., Li, X., Liao, Y., Peng, Z., Li, Y., Hou, L., Yuan, Z., & Cheng, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01842-0 · Cited by 148
Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia
Fan, Z., Liang, Z., Yang, H. M., Pan, Y., Zheng, Y., & Wang, X. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1036-x · Cited by 136
Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine
Jin, S., Zhang, L., & Wang, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115215 · Cited by 140
Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
Paudel, Y. N., Angelopoulou, E., Piperi, C., Shaikh, M. F., & Othman, I. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104593 · Cited by 115
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
Huang, P., Zhang, Z., Zhang, P., Feng, J., Xie, J., Zheng, Y., Liang, X., Zhu, B., Chen, Z., Feng, S., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03713-0 · Cited by 111
SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models
Kwon, O., Song, J., Yang, Y., Kim, S., Kim, J. Y., Seok, M., Hwang, I., Yu, J., Karmacharya, J., Maeng, H., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013076 · Cited by 110
A novel role of NLRP3-generated IL-1β in the acute-chronic transition of peripheral lipopolysaccharide-elicited neuroinflammation: implications for sepsis-associated neurodegeneration
Zhao, Z., Wang, Y., Zhou, R., Li, Y., Gao, Y., Tu, D., Wilson, B., Song, S., Feng, J., Hong, J.-S., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1728-5 · Cited by 109
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Peggion, C., Calí, T., & Brini, M. (2024) · Antioxidants · doi:10.3390/antiox13020240 · Cited by 112
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Han, Q.-Q., & Le, W. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01023-y · Cited by 106
Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
Rasheed, M., Liang, J., Wang, C., Deng, Y., & Chen, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094956 · Cited by 96
Neuroinflammation in Parkinson’s Disease – Putative Pathomechanisms and Targets for Disease-Modification
Grotemeyer, A., McFleder, R. L., Wu, J., Wischhusen, J., & Ip, C. W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878771 · Cited by 93
Activation of NLRP3 Inflammasome Promotes Foam Cell Formation in Vascular Smooth Muscle Cells and Atherogenesis Via HMGB1
Wang, R., Wu, W., Li, W., Huang, S., Li, Z., Liu, R.-M., Shan, Z., Zhang, C., Li, W., & Wang, S. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008596 · Cited by 89
Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
Guan, Y., & Han, F. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00037 · Cited by 90
Evidence for the Role of Mitochondrial DNA Release in the Inflammatory Response in Neurological Disorders
Moya, G. E., Rivera, P. D., & Dittenhafer‐Reed, K. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137030 · Cited by 90
Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
Nguyen, L. T. N., Nguyễn, H. Đ., Kim, Y. J., Nguyen, T. T., Lai, T. T., Lee, Y. K., Ma, H., & Kim, Y. E. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223290 · Cited by 90
Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation
Chen, C., Wei, Y.-Z., He, X., Li, D., Wang, G., Li, J.-J., & Zhang, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00936 · Cited by 85
Microglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 89
MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson's disease mouse model
Sun, Q., Wang, S., Chen, J., Cai, H., Huang, W., Zhang, Y., Wang, L., & Xing, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28907 · Cited by 82
Neurovascular Inflammaging in Health and Disease
Mészáros, Á., Molnár, K., Nógrádi, B., Hernádi, Z., Nyúl‐Tóth, Á., Wilhelm, I., & Krizbai, I. A. (2020) · Cells · doi:10.3390/cells9071614 · Cited by 86
Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
Cui, Y., Yu, H., Bu, Z., Wen, L., Yan, L.-L., & Feng, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894298 · Cited by 80
Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model
Huang, S., Liu, H., Lin, Y., Liu, M., Lǐ, Y., Mao, H., Zhang, Z., Zhang, Y., Ye, P., Ding, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618787 · Cited by 80
Targeting NLRP3 inflammasome for neurodegenerative disorders
Yao, J., Wang, Z., Song, W., & Zhang, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02239-0 · Cited by 81
PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
Mogensen, F. L., Scafidi, A., Poli, A., & Michelucci, A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02776-z · Cited by 80
Targeting Inflammasomes to Treat Neurological Diseases
Lünemann, J. D., Malhotra, S., Shinohara, M. L., Montalbán, X., & Comabella, M. (2021) · Annals of Neurology · doi:10.1002/ana.26158 · Cited by 73
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
Possemato, E., Barbera, L. L., Nobili, A., Krashia, P., & D’Amelio, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101907 · Cited by 76
α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1–42-stimulated murine astrocytes
Ebrahimi, T., Rust, M. I., Kaiser, S., Slowik, A., Beyer, C., Koczulla, A. R., Schulz, J. B., Habib, P., & Bach, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1319-x · Cited by 72
NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin
Yan, Y., Fang, Y., Zheng, R., Pu, J., & Zhang, B. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.004 · Cited by 72
Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
Armentero, M., Cerri, S., & Blandini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00232 · Cited by 75
miR‐29c‐3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease
Wang, R., Li, Q., He, Y., Yang, Y., Ma, Q., & Li, C. (2020) · Genes to Cells · doi:10.1111/gtc.12764 · Cited by 64
NLRP3 inflammasome in health and disease (Review)
Wang, H., Ma, L., Su, W., Liu, Y., Xie, N., & Liu, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5489 · Cited by 70
Role of Microgliosis and NLRP3 Inflammasome in Parkinson’s Disease Pathogenesis and Therapy
de Araújo, F. M., Cuenca‐Bermejo, L., Fernández‐Villalba, E., Costa, S. L., da Silva, V. D. A., & Herrero, M. T. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01027-6 · Cited by 63
Inhibiting NLRP3 inflammasome with MCC950 ameliorates perioperative neurocognitive disorders, suppressing neuroinflammation in the hippocampus in aged mice
Fu, Q., Li, J., Qiu, L., Ruan, J., Mao, M., Li, S., & Mao, Q.-H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106317 · Cited by 61
Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment
Wu, X., Wan, T., Gao, X., Fu, M., Duan, Y., Shen, X., & Guo, W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.922331 · Cited by 64
Long-term, West Nile virus-induced neurological changes: A comparison of patients and rodent models
Fulton, C. M., Beasley, D. W. C., Bente, D. A., & Dineley, K. T. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100105 · Cited by 59
Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer’s and Parkinson’s Disease
Hulse, J. P., & Bhaskar, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805169 · Cited by 63
NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors
Xu, Y., Yang, Y., Chen, X., Jiang, D., Zhang, F., Guo, Y., Hu, B., Xu, G., Peng, S., Wu, L., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00381-x · Cited by 65
NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP–Treated NLRP3 Knockout Mice
Ou, Z., Zhou, Y., Wang, L., Xue, L., Zheng, J., Chen, L., & Tong, Q. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02198-5 · Cited by 59
Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson’s disease model
Qiu, X., Wang, Q., Hou, L., Zhang, C., Wang, Q., & Zhao, X. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.05.008 · Cited by 59
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111428 · Cited by 59
NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease
Khot, M., Sood, A., Tryphena, K. P., Khan, S. S., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175300 · Cited by 56
Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson's disease
Huang, J., Zhang, X., Yang, X., Yv, Q., Ye, F., Chen, S., Cui, Y., Gu, L., Zhu, M., & Li, W. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110820 · Cited by 53
Therapeutic Role of Inflammasome Inhibitors in Neurodegenerative Disorders
Lahooti, B., Chhibber, T., Bagchi, S., Varahachalam, S. P., & Jayant, R. D. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.004 · Cited by 50
Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
Duan, Y., Kelley, N., & He, Y. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.272576 · Cited by 50
Antrodia camphorata polysaccharide resists 6‐OHDA‐induced dopaminergic neuronal damage by inhibiting ROS‐NLRP3 activation
Han, C., Shen, H., Yang, Y., Sheng, Y., Wang, J., Li, W., Zhou, X., Guo, L., Zhai, L., & Guan, Q. (2020) · Brain and Behavior · doi:10.1002/brb3.1824 · Cited by 49
Sleep Disruption Worsens Seizures: Neuroinflammation as a Potential Mechanistic Link
Bonilla‐Jaime, H., Zeleke, H., Rojas, A., & Espinosa‐García, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212531 · Cited by 53
SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
Al-Kuraishy, H. M., Al-Gareeb, A. I., Kaushik, A. K., Kujawska, M., Ahmed, E., & Batiha, G. E. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25171 · Cited by 47
Neuroprotective Effects of Safflower Flavonoid Extract in 6-Hydroxydopamine-Induced Model of Parkinson’s Disease May Be Related to its Anti-Inflammatory Action
Lei, H., Ren, R., Sun, Y. X., Zhang, K., Zhao, X. S., Ablat, N., & Pu, X. (2020) · Molecules · doi:10.3390/molecules25215206 · Cited by 46
Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases
Litwiniuk, A., Baranowska-Bik, A., Domańska, A., Kalisz, M., & Bik, W. (2021) · Pharmaceuticals · doi:10.3390/ph14121221 · Cited by 46
Through Reducing ROS Production, IL-10 Suppresses Caspase-1-Dependent IL-1β Maturation, thereby Preventing Chronic Neuroinflammation and Neurodegeneration
Gao, Y., Tu, D., Yang, R., Chu, C., Hong, J., & Gao, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020465 · Cited by 46
NLRP3 Inflammasome-Related Proteins Are Upregulated in the Putamen of Patients With Multiple System Atrophy
Li, F., Ayaki, T., Maki, T., Sawamoto, N., & Takahashi, R. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly090 · Cited by 44
Microglial NLRP3 Inflammasome Induces Excitatory Synaptic Loss Through IL-1β-Enriched Microvesicle Release: Implications for Sepsis-Associated Encephalopathy
Moraes, C. A., Hottz, E. D., Dos Santos Ornellas, D., Adesse, D., de Azevedo, C. T., d’Avila, J. C., Zaverucha-do-Valle, C., Maron-Gutierrez, T., Barbosa, H. S., Bozza, P. T., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03067-z · Cited by 43
Cigarette smoke-induced inflammation: NLRP10-mediated mechanisms
Kaur, G., Bagam, P., Pinkston, R., Singh, D. P., & Batra, S. (2018) · Toxicology · doi:10.1016/j.tox.2018.02.010 · Cited by 43
Inflammasomes in CNS Diseases
Albornoz, E. A., Woodruff, T. M., & Gordon, R. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_3 · Cited by 42
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis
Jiang, X., Wu, K., Ye, X., Xie, T., Zhang, P., Blass, B. E., & Bai, R. (2023) · Medicinal Research Reviews · doi:10.1002/med.21939 · Cited by 40
Suppression of Presymptomatic Oxidative Stress and Inflammation in Neurodegeneration by Grape-Derived Polyphenols
Herman, F. J., Westfall, S., Brathwaite, J. S., & Pasinetti, G. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00867 · Cited by 43
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
Datta, N., Johnson, C., Kao, D. H., Gurnani, P., Alexander, C., Polytarchou, C., & Monaghan, T. M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106870 · Cited by 42
NLRP3 Inflammasome Blockade Reduces Cocaine-Induced Microglial Activation and Neuroinflammation
Chivero, E. T., Thangaraj, A., Tripathi, A., Periyasamy, P., Guo, M., & Buch, S. J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02184-x · Cited by 38
The “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders
Rimessi, A., Patergnani, S., Morciano, G., Carinci, M., Leo, S., & Pinton, P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339473 · Cited by 41
Cerebrovascular inflammation: A critical trigger for neurovascular injury?
Naveed, M., Zhou, Q., & Han, F. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.011 · Cited by 37
Down-regulation of DJ-1 Augments Neuroinflammation via Nrf2/Trx1/NLRP3 Axis in MPTP-induced Parkinson’s Disease Mouse Model
Ji, Y.-J., Wang, H., Yin, B.-L., & Ren, X. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.06.001 · Cited by 38
Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases
Akter, R., Rahman, H., Behl, T., Chowdhury, M. A. R., Manirujjaman, M., Bulbul, I. J., Elshenawy, S. E., Ţiţ, D. M., & BUNGAU, S. G. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210218084444 · Cited by 40
The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases
He, W., Hu, Z., Zhong, Y., Wu, C., & Li, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03229-7 · Cited by 38
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36
The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain
Maran, J. J., Adesina, M. M., Green, C. R., Kwakowsky, A., & Mugisho, O. O. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101954 · Cited by 38
BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson’s disease
Ying, Z.-M., Lv, Q.-K., Yao, X., Dong, A.-Q., Yang, Y., Cao, Y.-L., Wang, F., Ai-ping, G., & Liu, C. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5159 · Cited by 34
Self-citation
Gut–Brain Axis: Focus on Sex Differences in Neuroinflammation
Caldarelli, M., Rio, P., Marrone, A., Ocarino, F., Chiantore, M., Candelli, M., Gasbarrini, A., Gambassi, G., & Cianci, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105377 · Cited by 37
Neuroinflammation in Age-Related Neurodegenerative Diseases: Role of Mitochondrial Oxidative Stress
Abadin, X., de Dios, C., Zubillaga, M., Ivars, E., Puigròs, M., Marí, M., Morales, A., Vizuete, M., Vitórica, J., Trullás, R., et al. (2024) · Antioxidants · doi:10.3390/antiox13121440 · Cited by 41
Inhibition of Long Non-Coding RNA KCNQ1OT1 Attenuates Neuroinflammation and Neuronal Apoptosis Through Regulating NLRP3 Expression via Sponging miR-30e-3p
Song, A., Yang, Y., He, H., Sun, J., Chang, Q., & Xue, Q. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s291274 · Cited by 33
Neuroprotective effects of natural cordycepin on LPS-induced Parkinson’s disease through suppressing TLR4/NF-κB/NLRP3-mediated pyroptosis
Sun, Y. J., Huang, W.-M., Tang, P.-C., Zhang, X., Zhang, X.-Y., Yu, B.-C., Fan, Y. M., Ge, X., & Zhang, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104274 · Cited by 33
Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson’s Disease
Ahmed, S., Panda, S. R., Kwatra, M., Sahu, B. D., & Naidu, V. G. M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00550 · Cited by 33
Quercetin Alleviated Inflammasome-Mediated Pyroptosis and Modulated the mTOR/P70S6/P6/eIF4E/4EBP1 Pathway in Ischemic Stroke
Alattar, A., Alshaman, R., Althobaiti, Y. S., Soliman, G. M., Ali, H. S., Khubrni, W. S., Koh, P., Rehman, N. U., & Shah, F. A. (2023) · Pharmaceuticals · doi:10.3390/ph16081182 · Cited by 32
Short-Chain Fatty Acid Aggregates Alpha-Synuclein Accumulation and Neuroinflammation via GPR43-NLRP3 Signaling Pathway in a Model Parkinson’s Disease
Qu, Y., An, K., Wang, D., Yu, H., Li, J., Min, Z., Xiong, Y., Xue, Z., & Mao, Z. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04726-7 · Cited by 30
Self-citation
The role and therapeutic potential of connexins, pannexins and their channels in Parkinson's disease
Ahmadian, E., Eftekhari, A., Samiei, M., Dizaj, S. M., & Vinken, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.03.010 · Cited by 31
Molecular mechanisms of cordycepin emphasizing its potential against neuroinflammation: An update
Govindula, A., Pai, A., Baghel, S. S., & Mudgal, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174364 · Cited by 32
Heat‐killed Lactobacillus murinus confers neuroprotection against dopamine neuronal loss by targeting NLRP3 inflammasome
Fan, H., Sheng, S., Li, D., Li, J., Wang, G., & Zhang, F. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10455 · Cited by 31
Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease
Redenšek, S., Flisar, D., Kojović, M., Kramberger, M. G., Georgiev, D., Pirtošek, Z., Trošt, M., & Dolžan, V. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1439-y · Cited by 29
Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 inﬂammasome in MPTP-induced Parkinson disease in mice
Liu, Q., Guo, X., Huang, Z., He, Q., Zhu, D., Zhang, S., Peng, Z., Che, Y., & Feng, X. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112539 · Cited by 29
The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson’s disease
Xie, A., Wang, J., Zhang, X., Fang, J.-N., Hua, F.-F., Han, J.-Y., & Yuan, Z. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.323077 · Cited by 28
Bushen‐Yizhi Formula Alleviates Neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson’s Disease
Mo, Y., Xu, E., Wei, R., Le, B., Song, L., Li, D., Chen, Y., Ji, X., Fang, S., Shen, J., et al. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/3571604 · Cited by 27
Sirtuin dysregulation in Parkinson's disease: Implications of acetylation and deacetylation processes
Dhiman, S., Mannan, A., Taneja, A., Mohan, M., & Singh, T. G. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122537 · Cited by 25

Authors: Mao, Z., Liu, C., Ji, S., Yang, Q., Ye, H., Han, H., & Xue, Z.
Affiliations: Tongji Hospital (CN)
Guangzhou First People's Hospital (CN)
Corresponding author: Xue, Zheng
ORCID: Ji, Suqiong
Yang, Qingmei
Han, Haiyan
Xue, Zheng
Venue: Neurochemical Research
Publisher: Springer Science and Business Media LLC
Published: 2017-02-28
Volume: 42
Issue: 4
Pages: 1104-1115
ISSN: 0364-3190 (ISSN-L)
1573-6903
DOI: 10.1007/s11064-017-2185-0
OpenAlex: W2592822773
Cited by: 155
References: 52
Citations by year: 2026: 4 · 2025: 13 · 2024: 16 · 2023: 21 · 2022: 20 · 2021: 27 · 2020: 26 · 2019: 12 · 2018: 12 · 2017: 4
FWCI: 10.35
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (unspecified)
Locations: Neurochemical Research (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China
Natural Science Foundation of Hubei Province
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Parkinson's disease, NLRP3 inflammasome, caspase-1, IL-1β, neuroinflammation, lipopolysaccharide-induced neurotoxicity, 6-hydroxydopamine, substantia nigra pars compacta, dopaminergic neurons, Ac-YVAD-cmk, rotational behavior, rat model
MeSH terms: NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Male, Random Allocation, Oxidopamine, Rats, Sprague-Dawley, Parkinsonian Disorders, Rats, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks